Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Retained Earnings (2009 - 2025)

Grifols' (GIFLF) quarterly Retained Earnings came in at $4.9 billion in Q4 2025, up 12.45% on a YoY basis from $4.3 billion in Q4 2024, and up 12.45% quarter-over-quarter from $4.3 billion in Q4 2024.

Analysis

Grifols (GIFLF) Retained Earnings (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Retained Earnings for 17 consecutive years, with $4.9 billion the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 12.45% year-over-year to $4.9 billion; the trailing twelve-month figure through Dec 2025 stood at $4.9 billion (up 12.45% YoY), and the FY2025 full-year result was $4.7 billion, up 9.15% from the prior year.
  • Retained Earnings grew to $4.9 billion in Q4 2025 per GIFLF's latest filing, from $4.3 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at $4.9 billion in Q4 2025 and bottomed at $4.1 billion in Q4 2022.
  • Historically, Retained Earnings has averaged $4.5 billion across 5 years, with a median of $4.3 billion in 2023.
  • The sharpest annual moves came in 2022 and 2025: Retained Earnings decreased 12.55% in 2022, then increased 12.45% in 2025.
  • Over 5 years, Retained Earnings stood at $4.7 billion in 2021, then slipped by 12.55% to $4.1 billion in 2022, then climbed by 5.14% to $4.3 billion in 2023, then dropped by 0.36% to $4.3 billion in 2024, then climbed by 12.45% to $4.9 billion in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods registered $4.9 billion, $4.3 billion, and $4.3 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn 558.00 Mn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -6.33 Bn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn 5.13 Bn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn 4.87 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.87 Bn
Dec 31, 2024 4.33 Bn
Dec 31, 2023 4.35 Bn
Dec 31, 2022 4.14 Bn
Dec 31, 2021 4.73 Bn
Dec 31, 2020 4.50 Bn
Sep 30, 2020 4.71 Bn
Mar 31, 2020 4.44 Bn
Dec 31, 2019 3.33 Bn
Sep 30, 2019 3.10 Bn
Dec 31, 2018 2.79 Bn
Sep 30, 2018 2.85 Bn
Jun 30, 2018 2.93 Bn
Mar 31, 2018 3.73 Bn
Dec 31, 2017 2.39 Bn
Jun 30, 2017 2.23 Bn
Dec 31, 2016 1.83 Bn
Sep 30, 2016 1.89 Bn
Jun 30, 2016 1.92 Bn
Dec 31, 2015 1.50 Bn